Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 11.08 % in the past year, substantial increase in net sales/revenue by 1.21 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 29.58 %. Marginal increase in other income during this quarter, up by 0.55%.
- Profit over the Year and quarter: Significant improvement in profitability for Dr. Lal Pathlabs Limited. Notable increase of 50.79 % in net profit Year to Year, Dr. Lal Pathlabs Limited’s profitability increased by 4.38 % in this quarter.
- EPS over the Year and quarter: EPS increased by 48.10 % Year to Year. EPS increased by 3.68 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 491 Cr | Rs. 538.9 Cr | Rs. 545.4 Cr | + 1.21 % | + 11.08 % |
| Expenses | Rs. 375.4 Cr | Rs. 398.3 Cr | Rs. 400.7 Cr | + 0.6 % | + 6.74 % |
| Operating Profit | Rs. 115.6 Cr | Rs. 140.6 Cr | Rs. 144.7 Cr | + 2.92 % | + 25.17 % |
| OPM % | 23.54 % | 26.09 % | 26.53 % | + 0.44 % | + 2.99 % |
| Other Income | Rs. 14.2 Cr | Rs. 18.3 Cr | Rs. 18.4 Cr | + 0.55 % | + 29.58 % |
| Interest | Rs. 9 Cr | Rs. 7 Cr | Rs. 6.6 Cr | -5.71 % | -26.67 % |
| Depreciation | Rs. 37.6 Cr | Rs. 36 Cr | Rs. 36.6 Cr | + 1.67 % | -2.66 % |
| Profit before tax | Rs. 83.2 Cr | Rs. 115.9 Cr | Rs. 119.9 Cr | + 3.45 % | + 44.11 % |
| Tax % | 31.61 % | 29.08 % | 28.44 % | -0.64 % | -3.17 % |
| Net Profit | Rs. 56.9 Cr | Rs. 82.2 Cr | Rs. 85.8 Cr | + 4.38 % | + 50.79 % |
| EPS in Rs | Rs. 6.84 | Rs. 9.77 | Rs. 10.13 | + 3.68 % | + 48.1 % |
Today, we’re looking at Dr. Lal Pathlabs Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 11.08 %. However, it did see a marginal increase of 1.21 % from the previous quarter. Expenses ticked up slightly by 0.6 % quarter-on-quarter, aligning with the annual rise of 6.74 %. Operating profit, while up 25.17 % compared to last year, faced a quarter-on-quarter increase of 2.92 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.99 %, but an expansion of 0.44 % sequentially. Other income rose by 0.55 % compared to the last quarter, despite an annual growth of 29.58 %. Interest expenses dropped significantly by -5.71 % from the previous quarter, yet the year-over-year decrease remains at a moderate -26.67 %. Depreciation costs climbed by 1.67 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -2.66 %. Profit before tax grew annually by 44.11 % but saw an increase from the preceding quarter by 3.45 %.
Tax expenses as a percentage of profits decreased slightly by -3.17 % compared to last year, with a more notable quarter-on-quarter decrease of -0.64 %. Net profit rose by 50.79 % year-on-year but experienced a 4.38 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 48.1 % but a quarterly rise of 3.68 %. In summary, Dr. Lal Pathlabs Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 491 Cr | Rs. 538.9 Cr | Rs. 545.4 Cr | + 1.21 % | + 11.08 % |
| Expenses | Rs. 375.4 Cr | Rs. 398.3 Cr | Rs. 400.7 Cr | + 0.6 % | + 6.74 % |
| Operating Profit | Rs. 115.6 Cr | Rs. 140.6 Cr | Rs. 144.7 Cr | + 2.92 % | + 25.17 % |
| Net Profit | Rs. 56.9 Cr | Rs. 82.2 Cr | Rs. 85.8 Cr | + 4.38 % | + 50.79 % |
| EPS in Rs | Rs. 6.84 | Rs. 9.77 | Rs. 10.13 | + 3.68 % | + 48.1 % |
In reviewing Dr. Lal Pathlabs Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 11.08 % year-on-year growth, however, there was a minor increase of 1.21 % from the previous quarter. Expenses rose by 6.74 % compared to the previous year, with a 0.6 % increase quarter-on-quarter. Operating Profit surged by 25.17 % annually, and saw a 2.92 % increase from the last quarter.
Net Profit showed yearly increase of 50.79 %, and experienced a 4.38 % increase from the previous quarter. Earnings Per Share (EPS) rose by 48.1 % annually, however rose by 3.68 % compared to the last quarter. In essence, while Dr. Lal Pathlabs Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
